Sign In

Joel Sendek

Chief Financial Officer at Dewpoint Therapeutics

Joel Sendek, a seasoned professional with a background in finance and healthcare, is currently serving as the Chief Financial Officer at Dewpoint Therapeutics.

He pursued his Bachelor of Arts (B.A.) in Biochemistry from Rice University, showcasing a strong educational foundation in the sciences.

With an impressive career trajectory, Joel has held notable positions including Chief Financial Officer at Sema4, Spero Therapeutics, and Forward Pharma A/S.

Prior to his role at Dewpoint Therapeutics, he leveraged his expertise as a Managing Director in Healthcare Equity Research at Stifel, as well as in similar positions at Lazard and Gerard Klauer Mattison.

Furthermore, Joel gained valuable experience in corporate development at Progenics Pharmaceuticals and began his professional journey as an analyst at Goldman, Sachs & Co.

His diverse roles in finance and healthcare underscore his extensive knowledge and proficiency in strategic financial management and corporate leadership.

Joel Sendek
Add to my network

Location

New York, New York, United States